Xeris制药公司今日盘中股价大涨9.81%,主要得益于公司公布的2024年第四季度财报表现出色。
根据公司最新的季度财报,Xeris制药实现营收6010万美元,同比大增35.39%,超出分析师预期的5810万美元。此外,公司本季度每股亏损0.03美元,较去年同期的0.10美元减少了70%,也优于分析师预期的0.06美元亏损。
良好的财报业绩显示,公司业务发展势头强劲、盈利能力持续改善,已步入健康发展轨道。这令投资者对公司未来前景更加看好,从而推高了公司股价在今日盘中的大涨表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.